A woman demonstrates the Avifavir antiviral drug approved to treat patients suffering from the coronavirus, at the unknown location, Russia. The Russian Direct Investment Fund (RDIF) and the ChemRar pharmaceutical company said on June 11 they started delivering Avifavir medication against COVID-19 to hospitals across the country. Avifavir, created on the basis of Favipiravir, is one of the two drugs for COVID-19 treatment registered globally. In early June, the Russian Health Ministry said that the medication had proven 90 percent efficient during trials.
- Package: Russia Coronavirus Antiviral Drug
- Categories: Human Interest, Social Issues, Health, Science & Technology
- Location: Russia
- Event date: 10.06.2020
- Date published: 11.06.2020
- Author: Andrey Rudakov
- Credit: Sputnik
- Source: Russian Direct Investment Fund (RDIF)
- Original: Digital
- Media: JPEG, 3539x2359px, 3.7Mb
- Job-ID: b67b68406eae2254